FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE; NOTICE OF MEETING; ESTABLISHMENT OF A PUBLIC DOCKET; REQUEST FOR COMMENTS-SOUTHERN HEMISPHERE INFLUENZA VIRUS VACCINES; CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) ALLERGEN STANDARDIZATION PROGRAM

WASHINGTON, Sept. 19 -- Food and Drug Administration has issued a notice called: Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Southern Hemisphere Influenza Virus Vaccines; Center for Biologics Evaluation and Research (CBER) Allergen Standardization Program.

The notice was published in the Federal Register on Sept. 19 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee (the Committee). The general function of the Committee is to provide advic...